A study published in a BMJ journal has found that inadequate screening in heart failure has cost the NHS an avoidable £21.5 million, writes PharmaTimes. The investigation identified the hidden costs due to under-managed but treatable iron deficiency (ID) and iron deficiency anaemia (IDA) from one-year data of around 80,000 people with heart failure.
The findings revealed that potentially a third of people with HF are not being screened for ID/IDA, with potentially debilitating effects on their quality of life. The data also revealed that those who have ID/IDA are more likely to be re-admitted to hospital within 30 days than those without ID, 95% of whom present as emergency admissions.
Researchers analyzed primary care data for 55,959 patients aged 45 and over with a new diagnosis of heart failure and 278,679 age and sex matched controls in the Clinical Practice Research Datalink from 1 January 2000 to 31 December 2017 and linked to inpatient Hospital Episode Statistics and Office for National Statistics mortality data.